Advanced Biomed Inc. ADVB
6.38
0.07
1.11%
as of 25 Sep
- Market cap
- $10.4M
- P/E
- 1.3×
Follow ADVB
| Jun '25 | Jun '24 | |
|---|---|---|
Current Ratio |
2.09 | 1.12 |
Net Debt/EBITDA |
1.08 | 1.22 |
Debt/Assets |
0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 |
Asset Turnover |
0.00 | — |
Operating CF/Net income |
1.79 | 0.76 |
Capex/Depreciation |
(0.09) | (0.19) |
Interest Coverage |
0.00 | 0.00 |
| (126.79%) | 0.00% | |
| (59.40%) | 0.00% | |
ROIC |
(329.11%) | 0.00% |
Return on Tangible Assets |
(93.79%) | (330.01%) |
Research and Development Expense of Revenue |
0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.02 | 0.03 |
Free Cash Flow per Share |
(5.71) | (2.20) |
Cash per Share |
2.83 | 2.61 |
Shareholders Equity per Share |
3.39 | 1.66 |
Interest Debt per Share |
0.00 | 0.00 |
Book value per Share |
3.39 | 1.66 |
Free Cash Flow |
(5.86) | (2.20) |
Working Capital |
3.14 | 0.32 |
Capital Expenditures |
(0.03) | (0.07) |
Net Current Asset Value |
3.00 | 0.25 |
| Other line items | ||
Quick Ratio |
1.01 | 0.95 |
Depreciation/Fixed assets |
1.04 | 0.76 |
Cash ROIC |
(96.47%) | (62.06%) |
Accounts Payable Turnover |
0.00 | — |
Average Days of Payables |
0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 |
Operating CF per Share |
(5.68) | (2.13) |
Capex per Share |
(0.03) | (0.07) |
Average Payables |
2.76 | — |
Average Assets |
5.49 | — |
Average Common Equity |
2.57 | — |
Capex to Sales |
0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% |
Columns are period end dates